cTAP Abstract for 2019 NORD Summit Categorising trajectories and individual item changes of the NSAA in patients with DMD 2019 EAN Abstract – Phase 1b/2 Study of RG6206 A Phase 1b/2 study of the anti-myostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy: A 72-week treatment update View the Full PDF
